Abstract
Artificial intelligence (AI) has emerged as a transformative force in psychiatry, improving diagnostic precision, treatment personalization, and early intervention through advanced data analysis techniques. This review explores recent advancements in AI applications within psychiatry, focusing on EEG and ECG data analysis, speech analysis, natural language processing (NLP), blood biomarker integration, and social media data utilization. EEG-based models have significantly enhanced the detection of disorders such as depression and schizophrenia through spectral and connectivity analyses. ECG-based approaches have provided insights into emotional regulation and stress-related conditions using heart rate variability. Speech analysis frameworks, leveraging large language models (LLMs), have improved the detection of cognitive impairments and psychiatric symptoms through nuanced linguistic feature extraction. Meanwhile, blood biomarker analyses have deepened our understanding of the molecular underpinnings of mental health disorders, and social media analytics have demonstrated the potential for real-time mental health surveillance. Despite these advancements, challenges such as data heterogeneity, interpretability, and ethical considerations remain barriers to widespread clinical adoption. Future research must prioritize the development of explainable AI models, regulatory compliance, and the integration of diverse datasets to maximize the impact of AI in psychiatric care.
1. Introduction: The Rise of Artificial Intelligence in Psychiatry
Medical diagnostic processes are vital in mental health, as in all fields of medicine. However, this process stands out as particularly problematic due to its complexity and subjective elements. Psychiatric diagnosis involves associating observed symptoms in patients with specific disease categories [1]. These symptoms represent the collected information during the assessment, while the diseases describe the abnormalities in these symptoms [2]. Over time, advancements in scientific medicine have more systematically defined diseases through causal chains and systems such as the International Classification of Diseases, structuring the diagnostic process more systematically [3]. Yet, these systems have not eliminated the error margin, increasing the need for technological solutions.
Artificial intelligence (AI) enables computers to mimic specific functions of human intelligence such as learning, reasoning, decision-making, and problem-solving [4,5,6]. Today, AI’s potential to revolutionize medicine and health services is noteworthy [7]. In particular, AI’s ability to analyze large volumes of data to provide accurate and fast results enhances the efficiency of clinical processes while reducing the workload of health professionals. In today’s world, where health expenses are rising and chronic diseases necessitate more frequent follow-ups, the focus on individuals’ quality of life is intensifying. Consequently, the solutions provided by AI are becoming increasingly important [8].
Psychiatry is a discipline known for its difficulty and complexity within the health sciences [9]. The diagnosis of psychiatric disorders typically relies on subjective assessments and clinical observations [10]. However, these processes often take a long time to reach an accurate diagnosis and establish an effective treatment method, requiring high expertise. These limitations in traditional approaches increase the importance of integrating AI-supported methods into psychiatry [11]. In particular, AI’s capabilities in data analysis, modeling, and prediction offer a revolutionary transformation by providing more objective and reliable results in psychiatric evaluation processes.
The rise of AI in the health field has been made possible by technological advancements and the applicability of machine learning (ML) methods to health data [12,13,14]. Initial steps were taken in the second half of the 20th century with the use of statistical methods and algorithms. The introduction of ML techniques into the health sector in the 1990s laid the groundwork for AI’s integration into psychiatry, and during this period, clinical decision support systems began to be developed. From the 2000s onwards, methods allowing for big data analysis and computers with high processing capacities have become widespread, making AI applications more sophisticated. Today, advanced AI technologies such as deep learning, natural language processing, and neural networks are actively used in diagnosing psychiatric disorders, analyzing symptoms, and personalizing treatment processes.
In light of these developments, AI is positioned not only as a clinical decision support tool but also as a solution that will enhance access to mental health services. Understanding the historical development and current applications of AI in psychiatry is crucial. This article will thoroughly examine the historical development of AI in psychiatry, its current applications, and its potential future impacts. The goal is to broadly evaluate the opportunities AI presents in psychiatry, the challenges encountered, and the ethical dimensions, thereby highlighting the contributions this technology can make to the field’s future. According to data from Web of Science (WOS), PubMed, ScienceDirect, and open-access publishers like MDPI, studies on artificial intelligence, deep learning, machine learning, and explainable AI in psychiatry have shown a significant increase in recent years. In particular, after 2020, the number of articles published in these fields has surged, reaching a peak in 2024. For example, in 2024, WOS published 1005 articles, PubMed 1276 articles, ScienceDirect 1353 articles, and MDPI 796 articles on machine learning, making it the most studied topic of the year (see Figure 1, Figure 2, Figure 3 and Figure 4). Under the category of artificial intelligence, a total of 6004 articles were published in PubMed, 3400 in WOS, 3915 in ScienceDirect, and 2517 in MDPI. Although explainable AI has fewer studies compared to other areas, there has been a notable increase by 2024, particularly with 78 articles in PubMed and 25 in WOS. Although the year 2025 has only recently begun, the number of early-access articles across all databases indicates that these fields are still on the rise. The data demonstrate that AI technologies are increasingly gaining academic and clinical interest in psychiatry and hold significant research potential in these areas.
Figure 1.
ScienceDirect Data: Psychiatry and AI Topics.
Figure 2.
PubMed Data: Psychiatry and AI Topics.
Figure 3.
WOS Data: Psychiatry and AI Topics.
Figure 4.
MDPI Data: Psychiatry and AI Topics.
2. Methodology
This review adopts the narrative review framework to explore the burgeoning intersection of AI and psychiatry. This approach was selected due to its suitability for synthesizing broad conceptual and methodological landscapes prevalent in nascent but rapidly evolving fields. The narrative method facilitates a comprehensive examination of diverse research outputs encompassing EEG, ECG, natural language processing (NLP), and AI’s application in analyzing social media data for psychiatric insights. The literature search was executed through an extensive examination of databases such as Web of Science (SCIE index), PubMed, and ScienceDirect. The search strategy was carefully crafted using a combination of keywords: ‘artificial intelligence AND psychiatry’, ‘EEG AND AI’, ‘ECG AND mental health’, ‘NLP AND psychiatry’, and ‘social media AND mental health surveillance’. This strategy aimed to encapsulate the multidisciplinary nature of AI applications across various facets of psychiatric research. The inclusion criteria mandated that studies must provide empirical data or substantial theoretical analysis on the application of AI within psychiatric settings. Articles were considered if they were published in peer-reviewed journals and were written in English. The exclusion criteria were set to omit articles not peer-reviewed, such as conference abstracts and opinion pieces, as well as studies that did not focus explicitly on AI applications in psychiatric contexts. Data from selected articles were meticulously extracted and included the following information: authors, year of publication, study aims, AI technology utilized, primary outcomes, and their implications for psychiatric practice. These data served as the foundation for a narrative synthesis aimed at threading together thematic consistencies and divergences across the selected studies. The synthesis process involved categorizing the articles according to the type of AI technology employed and its application within psychiatric practice. This categorization facilitated a detailed thematic analysis, allowing for an in-depth discussion of technological advancements, application challenges, and the potential trajectory of AI in psychiatry. The rigor of the selected studies was critically assessed based on their methodological soundness, the robustness of findings, and the prestige of the publication outlets. Such a critical appraisal was pivotal in ensuring that the conclusions drawn from the review were grounded in scientifically valid and methodologically sound evidence. In summary, this methodology section explicates the systematic procedures undertaken to gather and synthesize the relevant literature, underpinning the review’s objectives to chart AI’s transformative potential in psychiatry. The narrative review method, complemented by a stringent selection and synthesis process, ensures a comprehensive overview that highlights current innovations and delineates future research directions in the integration of AI technologies within psychiatric practices.
3. EEG and AI: New Horizons in Brain Wave Analysis
Electroencephalography (EEG) is a non-invasive method commonly used to measure brain activity and holds significant importance in neurological and psychiatric research due to its high temporal resolution [15]. EEG signals can map the detailed functions of the brain during various mental states, and based on these data, AI based models are being developed to detect disorders such as depression, schizophrenia, and bipolar disorder [16]. AI algorithms, when analyzing EEG signals, particularly utilize spectral features, band powers, and connectivity measures [17]. For example, findings related to low alpha and high beta powers derived from EEG signals are commonly used in the diagnosis of depression [18]. However, EEG data are susceptible to artifacts, necessitating controlled signal quality and the use of accurate data cleaning methods [19]. In particular, the removal of artifacts caused by eye movements and muscle activities enhances the accuracy of the analyses [20]. In recent years, deep learning techniques have played a significant role in disease detection and analyses to differentiate between brain activities using EEG data. For instance, in a study using deep neural networks, cases of treatment-resistant depression were classified with more than 90% accuracy compared to those responding to treatment [18]. Additionally, analyses of EEG signals from short-term and long-term recordings have been enhanced by functional connectivity analyses integrated with neuroimaging methods [21]. This section will thoroughly examine how EEG-based AI applications are utilized in areas such as emotional state detection, neurological disorder diagnosis, and treatment planning.
The studies summarized in this review reflect the significant advancements in EEG-based artificial intelligence applications for psychiatric and neurological research (see Table 1). These studies utilize a variety of ML and deep learning models, including CNNs, ensemble learning approaches, and advanced feature extraction methods such as wavelet scattering and functional connectivity analysis. This diversity in methodological approaches demonstrates the flexibility and adaptability of EEG signals for complex mental health evaluations.
Table 1.
State-of-the-Art Studies on EEG-Based AI in Psychiatry.
One notable observation is the widespread use of CNN architectures in several studies. For instance, the GoogleNet CNN employed by Metin et al. achieved a classification accuracy of 90.05% for treatment-resistant depression (TRD) with a notable external validation accuracy of 73.33% [18]. Despite this success, the retrospective design and moderate sample size highlight the common limitation of data scarcity and generalizability concerns in psychiatric EEG research. Similarly, Xia et al.’s work utilized data augmentation techniques, such as discrete cosine transform (DCT), to enhance the performance of EEGNet models for sleep pattern analysis, achieving an accuracy of 92.85% [23]. This underscores the necessity of individualized data augmentation to improve model robustness. Moreover, studies focusing on ensemble methods, such as the research by Chen et al., illustrate the potential of combining multiple classifiers to increase diagnostic accuracy. Their ensemble model reached an impressive accuracy of 97.4% for ADHD detection based on EEG and behavioral measures, although the sample size was limited to 78 children, raising concerns about the representativeness of the findings [30]. In contrast, random forest classifiers, as seen in Earl et al.’s study on MDD, demonstrated promising accuracy across different emotional stimuli (e.g., happy and sad videos) [22]. However, the study’s reliance on a small cohort and the need for independent validation reveal common pitfalls in EEG studies, such as overfitting and the lack of demographic variability. Functional connectivity analysis has emerged as a pivotal feature in EEG-based studies of depression and anxiety disorders. The work by Lee et al. utilized phase-locking value (PLV) analysis in MDD patients and found no significant differences between self-harming and non-self-harming groups, suggesting the complexity of functional connectivity markers in behavioral phenotyping [40]. Similarly, Catal et al.’s analysis of intrinsic time scales linked EEG dynamics to behavioral modulation, although the limited assessment of individual variability constrained the study’s broader implications [43]. These findings highlight the potential of connectivity metrics but also underscore the need for more extensive multi-center datasets to improve model generalization. Interestingly, the integration of EEG with multimodal data, such as fMRI and behavioral assessments, was exemplified by Kung et al., who demonstrated the importance of neurovascular coupling through the spectral analysis of EEG-fMRI data [29]. Multi-omics approaches, as seen in Corrivetti et al.’s study, further indicate that combining EEG with biological samples can enhance personalized treatment predictions for MDD [26]. However, these methods introduce additional challenges related to data standardization and multi-site consistency. Another prominent challenge in EEG studies is the handling of artifacts and noise. Many studies, including those by Earl et al. and Cerdan-Martinez et al., employed bandpass filtering and independent component analysis (ICA) to address signal contamination [22,28]. Despite these preprocessing steps, the variability in artifact removal approaches underscores the need for standardized preprocessing protocols to ensure reproducibility across studies.
Finally, the review reveals the growing interest in brain–computer interface (BCI) applications. Jia et al.’s TTSNet model for EEG-based multi-class classification achieved a relatively modest accuracy of 45.88%, highlighting the complexity of designing robust BCI systems [48]. This result underscores the limitations of current neural network models in real-time cognitive state recognition and emphasizes the need for simpler, yet efficient, architectures to improve classification performance. In summary, this review underscores the significant strides made in EEG-based ML research across a range of psychiatric conditions, including MDD, ADHD, schizophrenia, and stress-related disorders. However, the field continues to face recurring challenges related to small sample sizes, model generalization, and data heterogeneity. Future research should prioritize the development of standardized preprocessing methods, robust multimodal datasets, and interpretable ML models to address these limitations. By overcoming these barriers, EEG-based AI applications can become more reliable and impactful in clinical practice.
4. ECG and AI: The Link Between Heart Rhythm and Mental Health
Electrocardiography (ECG) plays a crucial role in measuring the electrical activity of the heart and is widely utilized not only for the detection of cardiovascular disorders but also for assessing mental health conditions. ECG data, particularly heart rate variability (HRV) measurements, have broad applications in identifying stress, anxiety, and depression [49,50]. Given the impact of brain–heart connections in mental disorders, changes in heart rhythm are often considered biological representations of emotional states [49,51]. In recent years, significant advancements have been made in ECG signal analysis using deep learning and AI methods. For instance, one-dimensional convolutional neural networks (1D-CNNs) have demonstrated high accuracy in classifying stress and depression by processing raw ECG signals directly [50]. These end-to-end approaches simplify the data processing pipeline by reducing the need for traditional feature extraction steps [52]. Additionally, some studies have shown that short-duration ECG segments, recorded at different time intervals, can effectively detect mental health disorders [53,54]. Notably, the analysis of ECG data obtained from portable devices offers significant advantages for monitoring outside clinical settings [55].
AI-based ECG analyses have also been enhanced through multimodal approaches for stress detection. For example, combining ECG signals with respiration and skin conductance data enables more precise monitoring of stress and relaxation states [56,57]. In conclusion, the use of AI-driven ECG analysis has emerged as a reliable biomarker in mental health assessments. However, challenges such as inter-subject variability and signal noise necessitate the improvement and standardization of data processing methods [58,59]. This section will explore how AI-based ECG applications can be integrated into clinical and everyday mental health evaluations.
The studies presented in Table 2 highlight the growing role of electrocardiography (ECG) in mental health assessments, leveraging various ML and deep learning (DL) methodologies to detect psychiatric and emotional disorders. A key observation across these studies is the increasing focus on end-to-end learning approaches that eliminate the need for manual preprocessing. For instance, the pre-processing-free deep learning model proposed by Abedinzadeh et al. [59] achieved a remarkable 99.35% accuracy for mental state classification using raw ECG data, demonstrating the robustness of transfer learning techniques for noisy signal environments. However, limited validation for noise resistance in diverse conditions underscores the need for broader testing. In parallel, scalogram-based methods, such as those by Abbas et al. [52], showed the advantage of 2D representations of ECG and EEG data in depression detection, attaining high sensitivity (96%) and specificity (95%). These results highlight the importance of feature extraction through time-frequency transformations for multimodal signals. However, as noted in the study, the real-time implementation of Internet of Things (IoT) systems for remote monitoring may face stability issues in data transmission. Ternary pattern-based signal classification models, like the one introduced by Tasci et al. [51], further emphasize the significance of interpretable machine learning. By employing majority voting and feature selection, the model achieved an overall accuracy of 96.25% across multiple psychiatric conditions, including bipolar disorder and schizophrenia. Nevertheless, dataset-specific limitations and single-lead configurations may hinder the generalizability of this approach to multi-lead or more complex datasets. Multimodal fusion frameworks have gained traction in emotional health assessments, as seen in the CNN–LSTM hybrid model by Shermadurai et al. [60]. This approach, which integrated EEG, ECG, and accelerometer data, reported an impressive classification accuracy of 94.58% for stress detection. However, the increased dimensionality of multimodal data presents computational challenges that require optimization strategies to avoid overfitting and reduce resource demands. Models using wavelet scattering and cardiopulmonary coupling (CPC), such as Zhang et al.’s [61] ResAttNet framework, further demonstrate how signal processing techniques enhance the detection of mental workload changes. While these methods showed improvements over traditional HRV-based models, they often rely heavily on specific datasets like MAUS, highlighting the importance of testing across broader and more heterogeneous samples. Another notable contribution is the 1D-CNN-based framework for mental fatigue detection by Chen et al. [62], which achieved an impressive accuracy of 98.44%. However, the small sample size (22 participants) and the limited time windows for data collection may constrain the model’s applicability in larger-scale settings. Hybrid architectures combining deep learning and attention mechanisms, such as the framework proposed by Geethanjali et al. [63], are emerging as powerful tools for maternal health risk detection. Despite achieving 98.4% accuracy, the need for more diverse datasets remains a significant limitation to ensuring the robustness of these models across different demographics and clinical contexts. The inclusion of vision transformers in the CNN ensemble proposed by Waheed Awan et al. [64] for emotional health assessment illustrates the potential of state-of-the-art transformer models in physiological data classification. With an accuracy of 98.2%, this approach demonstrates the potential of combining different neural network architectures for improved generalization. However, the long training times and computational demands of transformers pose challenges for real-time and mobile health applications. Finally, fine-tuned feature extraction models such as Tuncer et al.’s [65] “Cardioish” framework provide an explainable artificial intelligence (XAI) solution for cardiac disorder classification with over 99% accuracy. This approach underscores the importance of interpretability in clinical diagnostics but also highlights the time-consuming nature of detailed feature extraction processes. The review of these ECG-based models reveals that while ML and deep learning approaches have made significant strides in mental and emotional health detection, there are still challenges related to data variability, dataset imbalances, and the generalizability of single-channel versus multi-channel data (Telangore et al. [66]). Additionally, models must be validated with diverse datasets and tested for real-world scenarios to overcome demographic and technical limitations. Future research should focus on developing lightweight, interpretable, and adaptive models that balance computational efficiency with diagnostic accuracy. Integrating multimodal data streams and exploring domain adaptation techniques may further enhance the reliability of ECG-based AI systems in mental health evaluations.
Table 2.
State-of-the-Art ECG-Based Studies on Mental Health.
5. Speech Analysis and Artificial Intelligence: Detection of Emotional States
Speech analysis is a valuable tool for assessing individuals’ emotional and cognitive states as acoustic, prosodic, and linguistic features of speech often reflect underlying mental health conditions [72,73]. Acoustic features such as fundamental frequency, speech rate, energy intensity, and intonation, alongside prosodic features like pitch variation and sentence structure, provide critical insights into emotional states [74,75]. AI-based models, unlike traditional assessment methods, can process large speech datasets and deliver objective results while accounting for individual differences [76,77]. Recent studies have shown that deep learning frameworks significantly enhance the detection of emotional expressions through speech, achieving high accuracy rates [78]. This has made speech analysis an effective method for the early diagnosis of disorders such as depression, anxiety, and bipolar disorder [79,80]. Common indicators in speech patterns of individuals with depression include slower speech rates, monotonous tone, and prolonged pauses, which AI algorithms can accurately classify and support clinicians during the diagnostic process [81,82,83]. Moreover, remote assessments using voice logs and online conversations analyzed by AI models have demonstrated reliability in evaluating levels of depression, anxiety, and stress [84,85,86]. Speech-based emotional recognition systems have also proven effective in detecting conditions such as social phobia, schizophrenia, and post-traumatic stress disorder [87]. These systems can monitor shifts in emotional states during interactions between patients and healthcare providers, contributing to personalized treatment plans [88,89,90]. AI-driven speech analysis has also been integrated into mobile apps and online mental health support systems, enabling continuous monitoring of users’ emotional states and providing timely interventions [91,92]. The combination of AI with NLP has further enhanced the performance and accuracy of speech-based diagnostic tools [93,94]. However, challenges related to data privacy, ethical concerns, and transparency in AI decision-making processes must be addressed for widespread clinical adoption [95,96]. Additionally, the generalization of speech datasets across different cultural and linguistic contexts is essential for improving the robustness of these models [17,97].
In conclusion, AI-powered speech analysis holds significant promise for revolutionizing the assessment of emotional states and mental health conditions, and future advancements in data availability and model development are expected to further expand its clinical applications [98,99].
The research studies outlined in Table 3 highlight the growing integration of speech-based AI systems for detecting and classifying various mental health conditions. The use of both supervised and unsupervised learning models has demonstrated significant potential in identifying distinctive speech patterns related to psychiatric and neurological disorders. For example, Rezaii et al. [100] employed connected speech samples and a custom NLP classifier to classify variants of primary progressive aphasia (PPA) with an accuracy of 97.9%. However, their reliance on short speech samples raises concerns about capturing the full complexity of PPA-related speech disruptions. In schizophrenia research, large language models (LLMs) such as GPT and Llama have shown their capability in evaluating disorganized thought processes, achieving a notable 92% F1-score and demonstrating consistency comparable to expert ratings (Pugh et al. [101]). Despite this, a trade-off between the precision of the models and the interpretability of their outputs remains a challenge. Similarly, emotional speech recognition studies, such as the empirical analysis by Ahammed et al. [102], demonstrated exceptional classification accuracy across multiple datasets (e.g., 99.82% for TESS and 98.95% for SAVEE), leveraging Mel-frequency cepstral coefficients (MFCCs) and chroma features. Nevertheless, the lack of testing on larger real-world datasets limits the generalizability of these findings. Leite et al. [103] adopted an incremental learning approach for tracking bipolar disorder over a seven-month period, achieving an accuracy of 91.8% based on acoustic features such as pitch and energy. However, the overlapping classes in psychiatric speech data remain an obstacle, making it difficult to distinguish between different affective states. Additionally, Wang et al. [104] explored the use of semi-structured interviews and explainable AI (XAI) techniques for detecting loneliness in older adults, obtaining an accuracy of 88.9%. Despite achieving high recall scores, their study was constrained by a small gender-imbalanced sample, reflecting a broader issue in clinical AI research concerning demographic representation. In depressive disorder assessments, Park et al. [105] utilized speech samples from social media posts and classified depressive symptoms based on DSM-5 criteria. While this approach leveraged publicly available data, concerns about the reliability and authenticity of online speech content pose limitations for diagnostic accuracy. Furthermore, Ding et al. [106] used a multi-task deep learning model to analyze speech data from crisis hotline calls, achieving a 96% F1-score for suicide risk assessment. However, the small size of the dataset and the absence of multimodal inputs, such as video data, limit the robustness of their findings. Assistive technologies for visually impaired individuals, as explored by Rosi et al. [107], demonstrated the feasibility of combining speech and gesture recognition, achieving 96.3% accuracy using CNNs and OpenCV. However, limited real-world testing hinders the validation of these systems in dynamic real-life environments. Takeshige et al. [108] focused on Alzheimer’s disease detection through chatbot conversations, incorporating speech and facial feature extraction to distinguish Alzheimer’s patients from healthy participants with a 94% area-under-the-curve (AUC) score. Yet, the performance of such models remains highly dependent on the effectiveness of the chatbot interaction. Notably, the hybrid feature extraction approach by Taşcı et al. [109] demonstrated a 94.63% accuracy in detecting depression from speech audio signals by employing wavelet transforms and k-nearest neighbor (KNN) classification. While this model shows promise, further evaluation of larger and more diverse datasets is necessary to confirm its robustness across varied populations and settings.
Table 3.
State-of-the-Art Studies on Speech Analysis for Psychiatric Disorders.
Overall, these studies illustrate the versatility of speech-based AI models in the early detection and classification of various mental health conditions, including PPA, schizophrenia, depression, bipolar disorder, and Alzheimer’s disease. However, several challenges persist, such as the dependency on dataset quality, demographic biases, and the need for multimodal integration. Future research should focus on expanding dataset diversity, improving the interpretability of AI models, and enhancing robustness through longitudinal studies and multi-center trials. Additionally, ethical considerations regarding data privacy, transparency, and informed consent should be prioritized to ensure responsible implementation in real-world clinical settings.
6. Blood Tests and AI: New Approaches in Biomarker Analysis
The integration of AI in the analysis of blood-based biomarkers has revolutionized the understanding of the biological underpinnings of psychiatric disorders [110,111]. By processing complex and multidimensional data from blood samples, AI-based models can identify patterns linked to mental health conditions, such as depression, schizophrenia, and bipolar disorder, which are not discernible through traditional diagnostic methods [112,113]. These models utilize ML algorithms to analyze various biological markers, including inflammatory proteins, genetic expressions, and metabolic indicators, to classify and predict psychiatric disorders with enhanced precision [114,115]. One significant advancement is the use of multi-domain integration models that combine biomarkers from multiple sources, such as immune-inflammatory proteins and cognitive metrics, to improve the diagnostic differentiation between related psychiatric conditions [110]. Additionally, unsupervised clustering methods have enabled the discovery of subtypes within psychiatric disorders, offering more personalized treatment pathways [116,117]. The application of neural networks and advanced imaging of blood samples, such as scattergram images, has also emerged as a cost-effective method for detecting psychiatric conditions like schizophrenia with high classification accuracy [118,119]. Despite these advancements, challenges remain in the clinical validation and generalization of AI models across different populations and data sources [120,121]. The heterogeneity of psychiatric disorders requires large-scale studies and independent cohort validations to ensure robust and reproducible results [122,123]. Moreover, ethical considerations related to data privacy and the transparency of AI decision-making processes must be addressed to support the responsible implementation of these technologies in clinical settings [124,125].
In summary, the use of AI in the analysis of blood-based biomarkers represents a significant leap forward in precision psychiatry. By uncovering the molecular and genetic foundations of mental disorders, these approaches pave the way for more accurate diagnoses, early interventions, and personalized treatment plans [126].
7. Social Media and Psychiatry: A New Frontier in Mental Health Assessment
The increasing use of social media platforms has introduced novel avenues for understanding and addressing mental health challenges. Social media platforms such as Twitter, Facebook, and Reddit serve as rich sources of user-generated content, reflecting real-time emotional expressions, opinions, and health-related narratives [127,128]. These digital interactions provide valuable insights into public sentiment regarding psychiatric treatments and the lived experiences of individuals with mental disorders [129,130]. Studies leveraging ML and NLP have demonstrated that social media data can be used to predict and classify mental health outcomes, including depression, anxiety, and suicidality [131,132]. For example, ML models trained on social media conversations have achieved high levels of accuracy in detecting suicide risk factors and depressive narratives [133,134]. Additionally, social media analysis enables researchers to explore public perceptions of specific psychiatric interventions, such as antipsychotic medications, and identify misconceptions or concerns that may influence treatment adherence [135,136]. The COVID-19 pandemic has further highlighted the potential of social media as a tool for real-time mental health surveillance, with studies documenting shifts in anxiety levels and digital engagement patterns during lockdown periods [137,138]. However, challenges such as ethical considerations, privacy concerns, and the generalizability of findings across different cultural and linguistic groups must be addressed [139,140].
By combining AI-based tools with social media data, mental health professionals can gain a deeper understanding of the psychosocial impacts of global events, track public discourse on mental health, and develop targeted intervention strategies to support vulnerable populations [141,142]. Despite its promise, the integration of social media data into clinical practice requires robust validation and regulatory frameworks to ensure data integrity and user safety [132]. In this context, the following section will explore the potential of social media platforms as tools for early detection, intervention, and mental health promotion.
The utilization of large language models (LLMs) in the analysis of social media data for psychiatric research has emerged as a transformative approach, enabling more nuanced assessments of mental health conditions (see Table 4). Recent comparative studies, such as that by Gargari et al. [143], have demonstrated that LLMs like GPT-3.5 and GPT-4 outperform traditional NLP models in interpreting clinical cases based on DSM-5 criteria, although they face challenges with specific psychiatric disorders. This highlights the potential of LLMs for context-aware text interpretation while also emphasizing the importance of domain-specific fine-tuning. Similarly, Pugh et al. [101] explored thought disorder assessments in speech samples from schizophrenia patients using LLM-based models, revealing a trade-off between accuracy and consistency, indicating that while LLMs can capture complex linguistic patterns, their predictions can sometimes be inconsistent. A key strength of LLMs in psychiatry lies in their ability to process unstructured data from electronic health records (EHRs) and social media platforms. Turner et al. [144] utilized a semi-rule-based NLP pipeline for transdiagnostic psychiatry, achieving high classification accuracy (95–99%) across a large dataset of clinical notes (22,170 patients). However, the relatively low F1-scores (0.38–0.86) for certain labels suggest that nuanced clinical information may be lost in large-scale automated analyses. In contrast, studies like Botelle et al. [145], which employed fine-tuned BioBERT models for classifying text fragments related to interpersonal violence in mental health records, reported high precision and recall (89–98%). This underscores the value of pretrained transformer models in specialized tasks but also points to limitations in data diversity, which may hinder generalizability. In suicide risk prediction, LLM-based models have shown significant potential. Levis et al. [146] and Levis et al. [147] demonstrated that NLP-enhanced classification models applied to EHR notes from veterans identified high-risk individuals more accurately, with improvements in AUC scores (+19%). However, these models were constrained by their reliance on specific datasets, such as those from VA records, limiting their applicability to broader populations. Similarly, Tsui et al. [148] achieved an impressive AUC of 0.932 for predicting first-time suicide attempts using a combination of structured and unstructured data, but their results were influenced by historical data biases, indicating a need for more representative datasets. For speech-based mental health research, semantic analysis has proven effective in distinguishing psychosis-related speech markers. Studies like Çabuk et al. [149] and Arslan et al. [150] utilized POS tagging and SBERT-based embeddings to classify schizophrenia and schizophrenia spectrum disorders, achieving mean accuracies above 86%. These findings underscore the potential of LLMs in speech feature analysis for psychiatric disorders, although language dependency remains a challenge, as evidenced by their limited generalizability across non-English datasets. Additionally, Zaher et al. [151] demonstrated that narrative speech analysis could predict psychosis relapse within a two- to four-week timeframe, although large-scale validation remains necessary.
Table 4.
State-of-the-Art Studies on Social Media for Mental Health Analysis.
Overall, the integration of LLMs and NLP pipelines into social media and EHR analyses has advanced psychiatric research by improving the detection and prediction of mental health outcomes. However, as noted in studies by Kerz et al. [156] and Msosa et al. [167], there is a trade-off between model interpretability and predictive performance, particularly when explainable AI (XAI) methods are applied. Future research must address these limitations by incorporating diverse datasets, refining weak supervision techniques (e.g., Cusick et al. [171]), and developing robust frameworks for clinical validation. Such advancements will be essential to fully realize the potential of LLMs in enhancing mental healthcare delivery and suicide prevention efforts through social media analysis.
8. Open-Source Datasets for AI Applications in Psychiatry
The advancement of AI in the field of psychiatry is increasingly reliant on the availability and accessibility of diverse and high-quality datasets. These datasets are essential for training and validating AI models that are designed to understand, diagnose, and treat psychiatric disorders more effectively. As AI continues to permeate various aspects of psychiatric research, the need for open access to relevant data becomes paramount. This ensures that the development of AI tools remains transparent, reproducible, and ethical while also facilitating global collaboration among researchers. Table 5 provides a comprehensive overview of key open-source datasets that are pivotal for AI research in psychiatry. These datasets encompass a wide range of data types, including electroencephalogram (EEG), electrocardiogram (ECG), textual content, and multimodal information, reflecting the multifaceted nature of psychiatric conditions. The datasets listed have been curated for their utility in developing AI applications that can process complex biological, textual, and behavioral data in psychiatric settings. Each dataset is described with details about its features, data types, the total count of data points, and access links, providing researchers with vital resources to aid in their studies. By leveraging these open-source datasets, researchers can explore innovative approaches in psychiatric AI, such as developing predictive models for early diagnosis, enhancing patient monitoring through real-time data analysis, and personalizing treatment plans based on unique biomarkers. The ethical considerations, data quality, and standardization of these resources are also crucial for ensuring that AI applications in psychiatry are both scientifically valid and socially responsible.
Table 5.
Key Open-Source Datasets for Psychiatry Research.
9. Recent Advances and Future Trends in AI-Based Psychiatry
The field of AI in psychiatry is evolving rapidly, introducing innovative applications that enhance diagnostic accuracy, treatment personalization, and early intervention. In recent years, large language models (LLMs), NLP frameworks, and deep learning-based approaches have significantly improved the efficiency of clinical decision support systems. LLMs, with their capacity to process complex clinical narratives and diagnostic notes, have shown potential in identifying suitable candidates for advanced therapies, such as transcranial magnetic stimulation (TMS). Furthermore, multimodal approaches integrating data from electroencephalography (EEG) and functional magnetic resonance imaging (fMRI) have enabled more comprehensive analyses of neural activity patterns. These methods facilitate the identification of subtypes within psychiatric disorders, such as schizophrenia and bipolar disorder, by combining spatial and temporal neural information. Additionally, emotion recognition tools have advanced, supporting real-time mood tracking through mobile applications and wearable devices. By analyzing physiological data, such as heart rate variability and skin conductance, these AI-driven tools can provide real-time feedback on anxiety and stress levels, augmenting mental health monitoring.
A key trend for the future involves the enhancement of explainability in AI (XAI) models. Transparent and interpretable models are crucial for fostering trust among clinicians and patients, addressing ethical concerns, and improving usability in clinical settings. Moreover, the integration of diverse and multi-center datasets and international data-sharing networks is expected to enhance the generalizability of AI models across different cultural and demographic groups. Another promising avenue is the application of social media analysis in psychiatric research. By analyzing textual and audio data from social media platforms, researchers can identify early indicators of mental health crises, enabling the development of public health early-warning systems. However, this approach necessitates robust data privacy regulations and ethical frameworks to ensure responsible data usage. In summary, the use of AI in psychiatry holds great potential for improving early diagnosis, personalized treatment planning, and access to mental health services. Future advancements in data diversity, regulatory frameworks, and interdisciplinary collaborations will be essential for addressing existing challenges and unlocking the full potential of AI-driven innovations in mental healthcare.
10. Challenges and Limitations of AI in Psychiatry
The integration of AI into psychiatry presents several challenges and limitations that need to be addressed to fully harness its potential. One of the primary issues is data quality and availability. Psychiatric data are often heterogeneous, unstructured, and limited in size, which complicates the training of robust AI models. Comprehensive datasets that encompass diverse populations are essential to ensure reliability and accuracy across different clinical settings. Generalizability remains another significant concern as models trained on specific populations may underperform in different environments due to variations in language, culture, and demographics. Moreover, the interpretability of AI models remains a critical hurdle, particularly in the case of deep learning frameworks that function as opaque systems. The lack of transparency in such models can hinder their clinical adoption, making explainable AI (XAI) techniques indispensable for building trust among clinicians and patients.
Privacy, security, and ethical concerns surrounding sensitive psychiatric data also pose significant challenges. Ensuring compliance with data protection regulations and obtaining informed consent is vital to mitigate risks associated with AI deployment. Bias within AI models, inherited from training datasets, can perpetuate disparities in mental healthcare and reinforce existing inequalities. Effective measures to detect and mitigate bias are crucial to ensure fairness and equitable access to mental health services. Clinical integration poses another challenge as AI tools must fit seamlessly within healthcare workflows without creating additional burdens for clinicians. This requires user-friendly interfaces, comprehensive training programs, and supportive infrastructure. The validation and regulation of AI tools in psychiatry necessitate large-scale and multi-center studies to confirm their efficacy and ensure their generalizability. Regulatory frameworks must evolve to establish clear guidelines for the safe and ethical use of AI in psychiatric settings, ensuring that these technologies meet rigorous clinical standards.
11. Future Directions
Future research in the realm of AI and psychiatry should prioritize several key areas to fully harness the potential of AI technologies. First, there is a critical need to refine explainable AI (XAI) techniques. Enhancing the transparency of AI models will not only foster trust among clinicians and patients but will also facilitate regulatory approvals and integration into clinical practice. For instance, developing methods that can elucidate the decision-making processes of AI systems can help psychiatrists understand and validate the AI’s diagnostic and therapeutic recommendations. Additionally, the expansion of diverse datasets is crucial. Current AI models often suffer from biases that arise due to the homogeneity of the data on which they are trained. To address this, future efforts should focus on gathering and utilizing datasets that are representative of the global population, including varied demographics such as age, ethnicity, and socioeconomic status. This will help in developing AI systems that are effective and fair across diverse populations. Another vital area is the development of robust validated frameworks for clinical implementation. These frameworks should ensure that AI tools in psychiatry adhere to the highest standards of safety, reliability, and efficacy.
Collaboration between data scientists, clinicians, and regulatory bodies will be essential in creating guidelines and standards for the deployment of AI in clinical settings. Moreover, the integration of AI with emerging technologies such as genomics and neuroimaging could lead to groundbreaking advances in personalized psychiatry. For example, combining AI with genetic data could help predict individual responses to psychiatric medications, reducing the trial-and-error process in medication management. Ethical considerations must also be at the forefront of future research. As AI becomes more integrated into psychiatric care, researchers and practitioners must address issues related to privacy, consent, and the potential for AI to perpetuate or exacerbate inequalities in mental healthcare. Establishing ethical guidelines and conducting ongoing evaluations of AI applications will be essential to navigate these challenges. By addressing these challenges and limitations, AI has the potential to revolutionize psychiatric care, fostering more accurate diagnoses, enabling earlier interventions, and facilitating highly personalized treatment plans. The anticipated advancements could significantly enhance both the efficacy and efficiency of psychiatric services, ultimately leading to improved patient outcomes.
12. Conclusions
AI has emerged as a transformative tool in psychiatry, reshaping traditional diagnostic and treatment paradigms by analyzing complex biological, behavioral, and linguistic data. EEG-based AI applications have identified nuanced neural patterns linked to psychiatric disorders such as depression and schizophrenia, while ECG analyses leveraging heart rate variability have enhanced the detection of emotional and stress-related conditions. Similarly, speech analysis and NLP based techniques have enabled accurate assessments of cognitive and emotional states, advancing the detection and monitoring of thought disorders. The use of large language models (LLMs) has further expanded the potential of AI, supporting the interpretation of unstructured data for remote mental health monitoring. Emerging applications, such as AI-driven analyses of blood biomarkers, have opened new avenues for understanding the biological underpinnings of psychiatric disorders by integrating genetic, inflammatory, and metabolic data. Social media analysis has demonstrated potential for real-time mental health monitoring, offering valuable insights into population-level trends and early warnings for crises such as suicidality and anxiety surges.
Despite these advancements, significant challenges remain. The interpretability of deep learning models continues to hinder clinical adoption due to their opaque nature, while biases in training data pose risks of unequal outcomes. Additionally, the generalizability of AI models is often limited by the demographic composition of datasets, and privacy concerns surrounding sensitive psychiatric data present ethical and regulatory hurdles. To fully realize the transformative potential of AI in psychiatry, future research should prioritize expanding diverse and high-quality datasets, refining explainable AI (XAI) frameworks, and developing robust regulatory frameworks to ensure its safe and ethical deployment. Interdisciplinary collaboration between clinicians, data scientists, and policymakers is essential for addressing the current limitations and fostering innovation in the field. In conclusion, AI has the capacity to revolutionize psychiatric care by enhancing diagnostic accuracy, streamlining clinical workflows, and enabling personalized treatment strategies. By addressing existing limitations and maintaining ethical practices, AI-driven solutions can pave the way for a new era of precision psychiatry, ultimately improving mental health outcomes and accessibility for patients worldwide.
Author Contributions
Conceptualization: İ.B., B.T. and G.T.; Methodology: İ.B., B.T. and G.T.; Software: B.T.; Validation: İ.B., B.T. and G.T.; Formal Analysis: İ.B., B.T. and G.T.; Investigation: İ.B., B.T. and G.T.; Resources: B.T., G.T.; Data Curation: İ.B., B.T. and G.T.; Writing—Original Draft Preparation: B.T. and G.T.; Writing—Review and Editing: B.T. and G.T.; Visualization: İ.B., B.T. and G.T.; and Supervision: B.T.; Project Administration: B.T. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
Not applicable.
Conflicts of Interest
The authors declare no conflicts of interest.
References
- Zimmerman, M.; Morgan, T.A.; Stanton, K. The severity of psychiatric disorders. World Psychiatry 2018, 17, 258–275. [Google Scholar] [CrossRef] [PubMed]
- Feinstein, A.R. An analysis of diagnostic reasoning. I. The domains and disorders of clinical macrobiology. Yale J. Biol. Med. 1973, 46, 212. [Google Scholar]
- National Research Council. Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease; National Academies Press: Washington, DC, USA, 2011. [Google Scholar]
- Jarrahi, M.H. Artificial intelligence and the future of work: Human-AI symbiosis in organizational decision making. Bus. Horiz. 2018, 61, 577–586. [Google Scholar] [CrossRef]
- Liu, G.-D.; Li, Y.-C.; Zhang, W.; Zhang, L. A brief review of artificial intelligence applications and algorithms for psychiatric disorders. Engineering 2020, 6, 462–467. [Google Scholar] [CrossRef]
- Arslan, S.; Kaya, M.K.; Tasci, B.; Kaya, S.; Tasci, G.; Ozsoy, F.; Dogan, S.; Tuncer, T. Attention TurkerNeXt: Investigations into Bipolar Disorder Detection Using OCT Images. Diagnostics 2023, 13, 3422. [Google Scholar] [CrossRef]
- Aminizadeh, S.; Heidari, A.; Dehghan, M.; Toumaj, S.; Rezaei, M.; Navimipour, N.J.; Stroppa, F.; Unal, M. Opportunities and challenges of artificial intelligence and distributed systems to improve the quality of healthcare service. Artif. Intell. Med. 2024, 149, 102779. [Google Scholar] [CrossRef]
- Patel, S.; Park, H.; Bonato, P.; Chan, L.; Rodgers, M. A review of wearable sensors and systems with application in rehabilitation. J. Neuroeng. Rehabil. 2012, 9, 1–17. [Google Scholar] [CrossRef]
- Kendler, K.S. Toward a philosophical structure for psychiatry. Am. J. Psychiatry 2005, 162, 433–440. [Google Scholar] [CrossRef]
- Kessler, R.C.; Wittchen, H.-U.; Abelson, J.; Zhao, S.; Stone, A. Methodological issues in assessing psychiatric disorders with self-reports. In The Science of Self-Report: Implications for Research and Practice; Lawrence Erlbaum Associates Publishers: Mahwah, NJ, USA, 2000; pp. 229–255. [Google Scholar]
- Jiang, M.; Zhao, Q.; Li, J.; Wang, F.; He, T.; Cheng, X.; Yang, B.X.; Ho, G.W.; Fu, G. A Generic Review of Integrating Artificial Intelligence in Cognitive Behavioral Therapy. arXiv 2024, arXiv:2407.19422. [Google Scholar]
- Bohr, A.; Memarzadeh, K. The rise of artificial intelligence in healthcare applications. In Artificial Intelligence in Healthcare; Elsevier: Amsterdam, The Netherlands, 2020; pp. 25–60. [Google Scholar]
- Ray, A.; Bhardwaj, A.; Malik, Y.K.; Singh, S.; Gupta, R. Artificial intelligence and Psychiatry: An overview. Asian J. Psychiatry 2022, 70, 103021. [Google Scholar] [CrossRef]
- Sun, J.; Dong, Q.-X.; Wang, S.-W.; Zheng, Y.-B.; Liu, X.-X.; Lu, T.-S.; Yuan, K.; Shi, J.; Hu, B.; Lu, L. Artificial intelligence in psychiatry research, diagnosis, and therapy. Asian J. Psychiatry 2023, 87, 103705. [Google Scholar] [CrossRef] [PubMed]
- Noachtar, S.; Remi, J.; Kaufmann, E. EEG-Update. Klin. Neurophysiol. 2022, 53, 243–252. [Google Scholar] [CrossRef]
- Jafari, M.; Sadeghi, D.; Shoeibi, A.; Alinejad-Rokny, H.; Beheshti, A.; García, D.L.; Chen, Z.; Acharya, U.R.; Gorriz, J.M. Empowering precision medicine: AI-driven schizophrenia diagnosis via EEG signals: A comprehensive review from 2002–2023. Appl. Intell. 2024, 54, 35–79. [Google Scholar] [CrossRef]
- Jafari, M.; Shoeibi, A.; Khodatars, M.; Bagherzadeh, S.; Shalbaf, A.; García, D.L.; Gorriz, J.M.; Acharya, U.R. Emotion recognition in EEG signals using deep learning methods: A review. Comput. Biol. Med. 2023, 165, 107450. [Google Scholar] [CrossRef]
- Metin, S.Z.; Uyulan, Ç.; Farhad, S.; Ergüzel, T.T.; Türk, Ö.; Metin, B.; Çerezci, Ö.; Tarhan, N. Deep learning-based artificial Intelligence can differentiate treatment-resistant and responsive depression cases with high accuracy. Clin. EEG Neurosci. 2024, 56, 119–130. [Google Scholar] [CrossRef]
- Şahin Sadık, E.; Saraoğlu, H.M.; Canbaz Kabay, S.; Tosun, M.; Keskinkılıç, C.; Akdağ, G. Investigation of the effect of rosemary odor on mental workload using EEG: An artificial intelligence approach. Signal Image Video Process. 2022, 16, 497–504. [Google Scholar] [CrossRef]
- Anderer, P.; Roberts, S.; Schlögl, A.; Gruber, G.; Klösch, G.; Herrmann, W.; Rappelsberger, P.; Filz, O.; Barbanoj, M.J.; Dorffner, G. Artifact processing in computerized analysis of sleep EEG—A review. Neuropsychobiology 1999, 40, 150–157. [Google Scholar] [CrossRef]
- Erguzel, T.T.; Ozekes, S.; Sayar, G.H.; Tan, O.; Tarhan, N. A hybrid artificial intelligence method to classify trichotillomania and obsessive compulsive disorder. Neurocomputing 2015, 161, 220–228. [Google Scholar] [CrossRef]
- Earl, E.H.; Goyal, M.; Mishra, S.; Kannan, B.; Mishra, A.; Chowdhury, N.; Mishra, P. EEG based Functional Connectivity in Resting and Emotional States may identify Major Depressive Disorder using Machine Learning. Clin. Neurophysiol. 2024, 164, 130–137. [Google Scholar] [CrossRef]
- Xia, M.; Zhao, X.; Deng, R.; Lu, Z.; Cao, J. EEGNet classification of sleep EEG for individual specialization based on data augmentation. Cogn. Neurodynamics 2024, 18, 1539–1547. [Google Scholar] [CrossRef]
- Madhu, S.; Kumar, P.; Chandra, S. Ensemble Learning based EEG Classification–Investigating the Effects of Combined Yoga and Rajyog Meditation. J. Sci. Ind. Res. 2024, 84, 36–47. [Google Scholar]
- Liu, Y.; Xiang, Z.; Yan, Z.; Jin, J.; Shu, L.; Zhang, L.; Xu, X. CEEMDAN fuzzy entropy based fatigue driving detection using single-channel EEG. Biomed. Signal Process. Control 2024, 95, 106460. [Google Scholar] [CrossRef]
- Corrivetti, G.; Monaco, F.; Vignapiano, A.; Marenna, A.; Palm, K.; Fernández-Arroyo, S.; Frigola-Capell, E.; Leen, V.; Ibarrola, O.; Amil, B. Optimizing and predicting antidepressant efficacy in patients with major depressive disorder using multi-omics analysis and the Opade AI prediction tools. Brain Sci. 2024, 14, 658. [Google Scholar] [CrossRef] [PubMed]
- Cambay, V.Y.; Tasci, I.; Tasci, G.; Hajiyeva, R.; Dogan, S.; Tuncer, T. QuadTPat: Quadruple Transition Pattern-based explainable feature engineering model for stress detection using EEG signals. Sci. Rep. 2024, 14, 27320. [Google Scholar] [CrossRef]
- Cerdán-Martínez, V.; López-Segura, P.; Lucia-Mulas, M.J.; Sanz, P.R.; Alonso, T.O. Male and Female Brain Activity During the Screening of a Violent Movie: An EEG Study. J. Creat. Commun. 2024, 19, 259–275. [Google Scholar] [CrossRef]
- Kung, Y.-C.; Li, C.-W.; Hsu, A.-L.; Liu, C.-Y.; Wu, C.W.; Chang, W.-C.; Lin, C.-P. Neurovascular coupling in eye-open-eye-close task and resting state: Spectral correspondence between concurrent EEG and fMRI. NeuroImage 2024, 289, 120535. [Google Scholar] [CrossRef]
- Chen, I.-C.; Chang, C.-L.; Chang, M.-H.; Ko, L.-W. The utility of wearable electroencephalography combined with behavioral measures to establish a practical multi-domain model for facilitating the diagnosis of young children with attention-deficit/hyperactivity disorder. J. Neurodev. Disord. 2024, 16, 62. [Google Scholar] [CrossRef]
- Maschke, C.; O’Byrne, J.; Colombo, M.A.; Boly, M.; Gosseries, O.; Laureys, S.; Rosanova, M.; Jerbi, K.; Blain-Moraes, S. Critical dynamics in spontaneous EEG predict anesthetic-induced loss of consciousness and perturbational complexity. Commun. Biol. 2024, 7, 946. [Google Scholar] [CrossRef]
- Kim, J.S.; Song, Y.W.; Kim, S.; Lee, J.-Y.; Yoo, S.Y.; Jang, J.H.; Choi, J.-S. Resting-state EEG microstate analysis of internet gaming disorder and alcohol use disorder. Dialogues Clin. Neurosci. 2024, 26, 89–102. [Google Scholar] [CrossRef]
- Zhang, F.; Yang, C.; You, L.; Wang, X.; Yuan, Y.; Jeannès, R.L.B.; Shu, H.; Xiang, W. WS-BiLSTM-MA: Wavelet scattering-based BiLSTM with mixed attention block for MDD recognition using multi-channel EEG signals. IEEE Trans. Instrum. Meas. 2024, 74, 6500513. [Google Scholar] [CrossRef]
- Ouyang, A.; Zhang, C.; Adra, N.; Tesh, R.A.; Sun, H.; Lei, D.; Jing, J.; Fan, P.; Paixao, L.; Ganglberger, W. Effects of Aerobic Exercise on Brain Age and Health in Middle-Aged and Older Adults: A Single-Arm Pilot Clinical Trial. Life 2024, 14, 855. [Google Scholar] [CrossRef] [PubMed]
- Chen, I.-C.; Chang, C.-L.; Huang, I.-W.; Chang, M.-H.; Ko, L.-W. Electrophysiological functional connectivity and complexity reflecting cognitive processing speed heterogeneity in young children with ADHD. Psychiatry Res. 2024, 340, 116100. [Google Scholar] [CrossRef]
- Meinert, E.; Milne-Ives, M.; Sawyer, J.; Boardman, L.; Mitchell, S.; Mclean, B.; Richardson, M.; Shankar, R. Subcutaneous electroencephalography monitoring for people with epilepsy and intellectual disability: Co-production workshops. BJPsych Open 2025, 11, e3. [Google Scholar] [CrossRef] [PubMed]
- Hsu, A.-L.; Wu, C.-Y.; Ng, H.-Y.H.; Chuang, C.-H.; Huang, C.-M.; Wu, C.W.; Chao, Y.-P. Classification of mindfulness experiences from gamma-band effective connectivity: Application of machine-learning algorithms on resting, breathing, and body scan. Comput. Methods Programs Biomed. 2024, 257, 108446. [Google Scholar] [CrossRef] [PubMed]
- Gui, A.; Throm, E.; da Costa, P.; Penza, F.; Mayans, M.A.; Jordan-Barros, A.; Haartsen, R.; Leech, R.; Jones, E. Neuroadaptive Bayesian optimisation to study individual differences in infants’ engagement with social cues. Dev. Cogn. Neurosci. 2024, 68, 101401. [Google Scholar] [CrossRef]
- Pandey, P.; McLinden, J.; Rahimi, N.; Kumar, C.; Shao, M.; Spencer, K.; Ostadabbas, S.; Shahriari, Y. fNIRSNET: A multi-view spatio-temporal convolutional neural network fusion for functional near-infrared spectroscopy-based auditory event classification. Eng. Appl. Artif. Intell. 2024, 137, 109256. [Google Scholar] [CrossRef]
- Lee, H.-J.; Park, Y.-M.; Shim, M. Differences in Functional Connectivity between Patients with Depression with and without Nonsuicidal Self-injury. Clin. Psychopharmacol. Neurosci. 2023, 22, 451. [Google Scholar] [CrossRef]
- Zhang, H.; Xue, X.; Wen, J.; Li, Y.; Fan, C.; Ma, L.; Wang, H.; Zhang, M.; Zhang, S.; Hu, D. Hypnotherapy modulating early and late event-related potentials components of face processing in social anxiety. Front. Psychiatry 2024, 15, 1449946. [Google Scholar] [CrossRef]
- Ho, C.-C.; Peng, S.-J.; Yu, Y.-H.; Chu, Y.-R.; Huang, S.-S.; Kuo, P.-H. In perspective of specific symptoms of major depressive disorder: Functional connectivity analysis of electroencephalography and potential biomarkers of treatment response. J. Affect. Disord. 2024, 367, 944–950. [Google Scholar] [CrossRef]
- Çatal, Y.; Keskin, K.; Wolman, A.; Klar, P.; Smith, D.; Northoff, G. Flexibility of intrinsic neural timescales during distinct behavioral states. Commun. Biol. 2024, 7, 1667. [Google Scholar] [CrossRef]
- Moreau, Q.; Brun, F.; Ayrolles, A.; Nadel, J.; Dumas, G. Distinct social behavior and inter-brain connectivity in dyads with autistic individuals. Soc. Neurosci. 2024, 19, 124–136. [Google Scholar] [CrossRef] [PubMed]
- Dal Bò, E.; Cecchetto, C.; Callara, A.L.; Greco, A.; Mura, F.; Vanello, N.; Di Francesco, F.; Scilingo, E.P.; Gentili, C. Emotion perception through the nose: How olfactory emotional cues modulate the perception of neutral facial expressions in affective disorders. Transl. Psychiatry 2024, 14, 342. [Google Scholar] [CrossRef] [PubMed]
- Yang, F.; Zhu, H.; Cao, X.; Li, H.; Fang, X.; Yu, L.; Li, S.; Wu, Z.; Li, C.; Zhang, C. Impaired motor-to-sensory transformation mediates auditory hallucinations. PLoS Biol. 2024, 22, e3002836. [Google Scholar] [CrossRef] [PubMed]
- Thunström, A.O.; Carlsen, H.K.; Ali, L.; Larson, T.; Hellström, A.; Steingrimsson, S. Usability Comparison Among Healthy Participants of an Anthropomorphic Digital Human and a Text-Based Chatbot as a Responder to Questions on Mental Health: Randomized Controlled Trial. JMIR Hum. Factors 2024, 11, e54581. [Google Scholar] [CrossRef]
- Jia, H.; Han, S.; Caiafa, C.F.; Duan, F.; Zhang, Y.; Sun, Z.; Solé-Casals, J. Enabling temporal–spectral decoding in multi-class single-side upper limb classification. Eng. Appl. Artif. Intell. 2024, 133, 108473. [Google Scholar] [CrossRef]
- Habib, A.; Vaniya, S.N.; Khandoker, A.; Karmakar, C. MDDBranchNet: A Deep Learning Model for Detecting Major Depressive Disorder Using ECG Signal. IEEE J. Biomed. Health Inform. 2024, 28, 3798–3809. [Google Scholar] [CrossRef]
- Zang, X.; Li, B.; Zhao, L.; Yan, D.; Yang, L. End-to-end depression recognition based on a one-dimensional convolution neural network model using two-lead ECG signal. J. Med. Biol. Eng. 2022, 42, 225–233. [Google Scholar] [CrossRef]
- Tasci, B.; Tasci, G.; Dogan, S.; Tuncer, T. A novel ternary pattern-based automatic psychiatric disorders classification using ECG signals. Cogn. Neurodynamics 2024, 18, 95–108. [Google Scholar] [CrossRef]
- Abbas, Q.; Celebi, M.E.; AlBalawi, T.; Daadaa, Y. Brain and Heart Rate Variability Patterns Recognition for Depression Classification of Mental Health Disorder. Int. J. Adv. Comput. Sci. Appl. 2024, 15, 838–854. [Google Scholar] [CrossRef]
- Mehata, S.; Bhongade, R.A.; Rangaswamy, R. A Novel Deep Learningbased Model for the Efficient Classification of Electrocardiogram Signals. Cardiometry 2022, 24, 1033–1039. [Google Scholar]
- Hwang, B.; You, J.; Vaessen, T.; Myin-Germeys, I.; Park, C.; Zhang, B.-T. Deep ECGNet: An optimal deep learning framework for monitoring mental stress using ultra short-term ECG signals. Telemed. e-Health 2018, 24, 753–772. [Google Scholar] [CrossRef] [PubMed]
- Zhao, L.; Niu, X.; Wang, L.; Niu, J.; Zhu, X.; Dai, Z. Stress detection via multimodal multi-temporal-scale fusion: A hybrid of deep learning and handcrafted feature approach. IEEE Sens. J. 2023, 23, 27817–27827. [Google Scholar] [CrossRef]
- Seo, W.; Kim, N.; Kim, S.; Lee, C.; Park, S.-M. Deep ECG-respiration network (DeepER net) for recognizing mental stress. Sensors 2019, 19, 3021. [Google Scholar] [CrossRef] [PubMed]
- Moussa, M.M.; Alzaabi, Y.; Khandoker, A.H. Explainable computer-aided detection of obstructive sleep apnea and depression. IEEE Access 2022, 10, 110916–110933. [Google Scholar] [CrossRef]
- Ghosh, S.; Kim, S.; Ijaz, M.F.; Singh, P.K.; Mahmud, M. Classification of mental stress from wearable physiological sensors using image-encoding-based deep neural network. Biosensors 2022, 12, 1153. [Google Scholar] [CrossRef]
- Abedinzadeh Torghabeh, F.; Modaresnia, Y.; Hosseini, S.A. A Pre-Processing-Free Mental State Detection Model Using Noisy Ecg Plots and Deep Transfer Learning. Biomed. Eng. Appl. Basis Commun. 2024, 2450051. [Google Scholar] [CrossRef]
- Shermadurai, P.; Thiyagarajan, K. Classification of Human Mental Stress Levels Using a Deep Learning Approach on the K-EmoCon Multimodal Dataset. Trait. Signal 2024, 41, 2559. [Google Scholar] [CrossRef]
- Zhang, H.; Wang, Z.; Zhuang, Y.; Yin, S.; Chen, Z.; Liang, Y. Assessment of Mental Workload Level Based on PPG Signal Fusion Continuous Wavelet Transform and Cardiopulmonary Coupling Technology. Electronics 2024, 13, 1238. [Google Scholar] [CrossRef]
- Chen, R.; Wang, R.; Fei, J.; Huang, L.; Bi, X.; Wang, J. Mental fatigue recognition study based on 1D convolutional neural network and short-term ECG signals. Technol. Health Care 2024, 32, 3409–3422. [Google Scholar] [CrossRef]
- Geethanjali, R.; Valarmathi, A. A Deep Learning based Hybrid Model for Maternal Health Risk Detection and Multifaceted Emotion Analysis in Social Networks. Int. J. Appl. Math. Comput. Sci. 2024, 34, 565–577. [Google Scholar] [CrossRef]
- Awan, A.W.; Taj, I.; Khalid, S.; Usman, S.M.; Imran, A.S.; Akram, M.U. Advancing emotional health assessments: A hybrid deep learning approach using physiological signals for robust emotion recognition. IEEE Access 2024, 12, 141890–141904. [Google Scholar] [CrossRef]
- Tuncer, T.; Baig, A.H.; Aydemir, E.; Kivrak, T.; Tuncer, I.; Tasci, G.; Dogan, S. Cardioish: Lead-Based Feature Extraction for ECG Signals. Diagnostics 2024, 14, 2712. [Google Scholar] [CrossRef] [PubMed]
- Telangore, H.; Sharma, N.; Sharma, M.; Acharya, U.R. A Novel ECG-Based Approach for Classifying Psychiatric Disorders: Leveraging Wavelet Scattering Networks. Med. Eng. Phys. 2024, 135, 104275. [Google Scholar] [CrossRef]
- Sun, M.; Cao, X. A Mental Stress Classification Method Based on Feature Fusion Using Physiological Signals. J. Circuits Syst. Comput. 2024, 33, 2450016. [Google Scholar] [CrossRef]
- Mukherjee, P.; Halder Roy, A. A deep learning-based approach for distinguishing different stress levels of human brain using EEG and pulse rate. Comput. Methods Biomech. Biomed. Eng. 2024, 27, 2303–2324. [Google Scholar] [CrossRef]
- Sangeetha, S.; Immanuel, R.R.; Mathivanan, S.K.; Cho, J.; Easwaramoorthy, S.V. An Empirical Analysis of Multimodal Affective Computing Approaches for Advancing Emotional Intelligence in Artificial Intelligence for Healthcare. IEEE Access 2024, 12, 114416–114434. [Google Scholar] [CrossRef]
- Alzate, M.; Torres, R.; De la Roca, J.; Quintero-Zea, A.; Hernandez, M. Machine Learning Framework for Classifying and Predicting Depressive Behavior Based on PPG and ECG Feature Extraction. Appl. Sci. 2024, 14, 8312. [Google Scholar] [CrossRef]
- Ao, H.; Zhai, E.; Jiang, L.; Yang, K.; Deng, Y.; Guo, X.; Zeng, L.; Yan, Y.; Hao, M.; Song, T. Real-Time Cardiac Abnormality Monitoring and Nursing for Patient Using Electrocardiographic Signals. Cardiology 2025, 150, 25–35. [Google Scholar] [CrossRef]
- Monteith, S.; Glenn, T.; Geddes, J.; Whybrow, P.C.; Achtyes, E.; Bauer, M. Expectations for artificial intelligence (AI) in psychiatry. Curr. Psychiatry Rep. 2022, 24, 709–721. [Google Scholar] [CrossRef]
- Sommer, I.E.; de Boer, J.N. How to reap the benefits of language for psychiatry. Psychiatry Res. 2022, 318, 114932. [Google Scholar] [CrossRef]
- Wilson, B.S.; Tucci, D.L.; Moses, D.A.; Chang, E.F.; Young, N.M.; Zeng, F.-G.; Lesica, N.A.; Bur, A.M.; Kavookjian, H.; Mussatto, C. Harnessing the power of artificial intelligence in otolaryngology and the communication sciences. J. Assoc. Res. Otolaryngol. 2022, 23, 319–349. [Google Scholar] [CrossRef] [PubMed]
- Gosztolya, G.; Balogh, R.; Imre, N.; Egas-Lopez, J.V.; Hoffmann, I.; Vincze, V.; Tóth, L.; Devanand, D.P.; Pákáski, M.; Kálmán, J. Cross-lingual detection of mild cognitive impairment based on temporal parameters of spontaneous speech. Comput. Speech Lang. 2021, 69, 101215. [Google Scholar] [CrossRef]
- Vogel, A.P.; Sobanska, A.; Gupta, A.; Vasco, G.; Grobe-Einsler, M.; Summa, S.; Borel, S. Quantitative Speech Assessment in Ataxia—Consensus Recommendations by the Ataxia Global Initiative Working Group on Digital-Motor Markers. Cerebellum 2024, 23, 1128–1134. [Google Scholar] [CrossRef] [PubMed]
- Semel, B.M. Listening like a computer: Attentional tensions and mechanized care in psychiatric digital phenotyping. Sci. Technol. Hum. Values 2022, 47, 266–290. [Google Scholar] [CrossRef]
- Kim, A.Y.; Jang, E.H.; Lee, S.-H.; Choi, K.-Y.; Park, J.G.; Shin, H.-C. Automatic depression detection using smartphone-based text-dependent speech signals: Deep convolutional neural network approach. J. Med. Internet Res. 2023, 25, e34474. [Google Scholar] [CrossRef] [PubMed]
- Górriz, J.M.; Álvarez-Illán, I.; Álvarez-Marquina, A.; Arco, J.E.; Atzmueller, M.; Ballarini, F.; Barakova, E.; Bologna, G.; Bonomini, P.; Castellanos-Dominguez, G. Computational approaches to explainable artificial intelligence: Advances in theory, applications and trends. Inf. Fusion 2023, 100, 101945. [Google Scholar] [CrossRef]
- Tan, E.J.; Sommer, I.E.; Palaniyappan, L. Language and psychosis: Tightening the association. Schizophr. Bull. 2023, 49, S83–S85. [Google Scholar] [CrossRef]
- Schuller, B.W.; Amiriparian, S.; Batliner, A.; Gebhard, A.; Gerczuk, M.; Karas, V.; Kathan, A.; Seizer, L.; Löchner, J. Computational charisma—A brick by brick blueprint for building charismatic artificial intelligence. Front. Comput. Sci. 2023, 5, 1135201. [Google Scholar] [CrossRef]
- Hampsey, E.; Meszaros, M.; Skirrow, C.; Strawbridge, R.; Taylor, R.H.; Chok, L.; Aarsland, D.; Al-Chalabi, A.; Chaudhuri, R.; Weston, J. Protocol for rhapsody: A longitudinal observational study examining the feasibility of speech phenotyping for remote assessment of neurodegenerative and psychiatric disorders. BMJ Open 2022, 12, e061193. [Google Scholar] [CrossRef]
- Vetráb, M.; Egas-López, J.V.; Balogh, R.; Imre, N.; Hoffmann, I.; Tóth, L.; Pákáski, M.; Kálmán, J.; Gosztolya, G. Using spectral sequence-to-sequence autoencoders to assess mild cognitive impairment. In Proceedings of the ICASSP 2022—2022 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), Singapore, 23–27 May 2022; pp. 6467–6471. [Google Scholar]
- Liu, Y.; Xia, S.; Nie, J.; Wei, P.; Shu, Z.; Chang, J.A.; Jiang, X. aiMSE: Toward an AI-based online mental status examination. IEEE Pervasive Comput. 2022, 21, 46–54. [Google Scholar] [CrossRef]
- Stenum, J.; Cherry-Allen, K.M.; Pyles, C.O.; Reetzke, R.D.; Vignos, M.F.; Roemmich, R.T. Applications of pose estimation in human health and performance across the lifespan. Sensors 2021, 21, 7315. [Google Scholar] [CrossRef] [PubMed]
- Wagh, V.V.; Vyas, P.; Agrawal, S.; Pachpor, T.A.; Paralikar, V.; Khare, S.P. Peripheral blood-based gene expression studies in schizophrenia: A systematic review. Front. Genet. 2021, 12, 736483. [Google Scholar] [CrossRef] [PubMed]
- Kumar, M.; Abhayapala, T.D.; Samarasinghe, P. A preliminary investigation on frequency dependant cues for human emotions. Acoustics 2022, 4, 460–468. [Google Scholar] [CrossRef]
- Taylor, R.; Hampsey, E.; Mészáros, M.; Skirrow, C.; Strawbridge, R.; Chok, L.; Aarsland, D.; Al-Chalabi, A.; Chaudhuri, K.; Weston, J. Clinical Feasibility of Speech Phenotyping for Remote Assessment of Neurodegenerative and Psychiatric Disorders (RHAPSODY): A study protocol. Eur. Psychiatry 2022, 65, S163. [Google Scholar] [CrossRef]
- Kálmán, J.; Devanand, D.P.; Gosztolya, G.; Balogh, R.; Imre, N.; Tóth, L.; Hoffmann, I.; Kovács, I.; Vincze, V.; Pákáski, M. Temporal speech parameters detect mild cognitive impairment in different languages: Validation and comparison of the Speech-GAP Test® in English and Hungarian. Curr. Alzheimer Res. 2022, 19, 373–386. [Google Scholar] [CrossRef]
- Taptiklis, N.; Su, M.; Barnett, J.H.; Skirrow, C.; Kroll, J.; Cormack, F. Prediction of mental effort derived from an automated vocal biomarker using machine learning in a large-scale remote sample. Front. Artif. Intell. 2023, 6, 1171652. [Google Scholar] [CrossRef]
- Fristed, E.; Skirrow, C.; Meszaros, M.; Lenain, R.; Meepegama, U.; Cappa, S.; Aarsland, D.; Weston, J. A remote speech-based AI system to screen for early Alzheimer’s disease via smartphones. Alzheimer’s Dement. Diagn. Assess. Dis. Monit. 2022, 14, e12366. [Google Scholar] [CrossRef]
- Lu, T.; Yang, J.; Zhang, X.; Guo, Z.; Li, S.; Yang, W.; Chen, Y.; Wu, N. Crossmodal audiovisual emotional integration in depression: An event-related potential study. Front. Psychiatry 2021, 12, 694665. [Google Scholar] [CrossRef]
- Otero, J.F.A.; Caballer, O.S.; Marti-Puig, P.; Sun, Z.; Tanaka, T.; Solé-Casals, J. Preliminary Results on the Generation of Artificial Handwriting Data Using a Decomposition-Recombination Strategy. In Proceedings of the ICASSP 2022—2022 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), Singapore, 23–27 May 2022; pp. 1166–1170. [Google Scholar]
- Wu, X.; Cai, Y.; Lian, Z.; Leung, H.-f.; Wang, T. Generating natural language from logic expressions with structural representation. IEEE/ACM Trans. Audio Speech Lang. Process. 2023, 31, 1499–1510. [Google Scholar] [CrossRef]
- Elvevåg, B. Reflections on measuring disordered thoughts as expressed via language. Psychiatry Res. 2023, 322, 115098. [Google Scholar] [CrossRef]
- Barrett-Young, A.; Abraham, W.C.; Cheung, C.Y.; Gale, J.; Hogan, S.; Ireland, D.; Keenan, R.; Knodt, A.R.; Melzer, T.R.; Moffitt, T.E. Associations between thinner retinal neuronal layers and suboptimal brain structural integrity in a middle-aged cohort. Eye Brain 2023, 15, 25–35. [Google Scholar] [CrossRef] [PubMed]
- Liang, N.; Liu, S.; Li, X.; Wen, D.; Li, Q.; Tong, Y.; Xu, Y. A decrease in hemodynamic response in the right Postcentral cortex is Associated with Treatment-Resistant Auditory Verbal Hallucinations in Schizophrenia: An NIRS Study. Front. Neurosci. 2022, 16, 865738. [Google Scholar] [CrossRef] [PubMed]
- De Angel, V.; Lewis, S.; Munir, S.; Matcham, F.; Dobson, R.; Hotopf, M. Using digital health tools for the Remote Assessment of Treatment Prognosis in Depression (RAPID): A study protocol for a feasibility study. BMJ Open 2022, 12, e059258. [Google Scholar] [CrossRef] [PubMed]
- Compton, M.T.; Ku, B.S.; Covington, M.A.; Metzger, C.; Hogoboom, A. Lexical diversity and other linguistic measures in schizophrenia: Associations with negative symptoms and neurocognitive performance. J. Nerv. Ment. Dis. 2022, 211, 613–620. [Google Scholar] [CrossRef]
- Rezaii, N.; Hochberg, D.; Quimby, M.; Wong, B.; Brickhouse, M.; Touroutoglou, A.; Dickerson, B.C.; Wolff, P. Artificial intelligence classifies primary progressive aphasia from connected speech. Brain 2024, 147, 3070–3082. [Google Scholar] [CrossRef]
- Pugh, S.L.; Chandler, C.; Cohen, A.S.; Diaz-Asper, C.; Elvevåg, B.; Foltz, P.W. Assessing dimensions of thought disorder with large language models: The tradeoff of accuracy and consistency. Psychiatry Res. 2024, 341, 116119. [Google Scholar] [CrossRef]
- Ahammed, M.; Sheikh, R.; Hossain, F.; Liza, S.M.; Rahman, M.A.; Mahmud, M.; Brown, D.J. Speech Emotion Recognition: An Empirical Analysis of Machine Learning Algorithms Across Diverse Data Sets. In Proceedings of the International Conference on Applied Intelligence and Informatics; Springer: Cham, Switzerland, 2023; pp. 32–46. [Google Scholar]
- Leite, D.; Casalino, G.; Kaczmarek-Majer, K.; Castellano, G. Incremental learning and granular computing from evolving data streams: An application to speech-based bipolar disorder diagnosis. Fuzzy Sets Syst. 2025, 500, 109205. [Google Scholar] [CrossRef]
- Wang, N.; Goel, S.; Ibrahim, S.; Badal, V.D.; Depp, C.; Bilal, E.; Subbalakshmi, K.; Lee, E. Decoding loneliness: Can explainable AI help in understanding language differences in lonely older adults? Psychiatry Res. 2024, 339, 116078. [Google Scholar] [CrossRef]
- Park, D.; Lee, G.; Kim, S.; Seo, T.; Oh, H.; Kim, S.J. Probability-based multi-label classification considering correlation between labels–focusing on DSM-5 depressive disorder diagnostic criteria. IEEE Access 2024, 12, 70289–70296. [Google Scholar] [CrossRef]
- Ding, Z.; Zhou, Y.; Dai, A.-J.; Qian, C.; Zhong, B.-L.; Liu, C.-L.; Liu, Z.-T. Speech based suicide risk recognition for crisis intervention hotlines using explainable multi-task learning. J. Affect. Disord. 2025, 370, 392–400. [Google Scholar] [CrossRef]
- Rosi, A.; Rose, S.R.; Murugan, C.A.; Balamurugan, E.; Priya, M.S.; Lalitha, K. Automated Gesture Recognition using Deep Learning Model for Visually Challenged People. In Proceedings of the 2024 International Conference on Advances in Computing, Communication and Applied Informatics (ACCAI), Chennai, India, 9–10 May 2024; pp. 1–6. [Google Scholar]
- Takeshige-Amano, H.; Oyama, G.; Ogawa, M.; Fusegi, K.; Kambe, T.; Shiina, K.; Ueno, S.-i.; Okuzumi, A.; Hatano, T.; Motoi, Y. Digital detection of Alzheimer’s disease using smiles and conversations with a chatbot. Sci. Rep. 2024, 14, 26309. [Google Scholar] [CrossRef] [PubMed]
- Taşcı, B. Multilevel hybrid handcrafted feature extraction based depression recognition method using speech. J. Affect. Disord. 2024, 364, 9–19. [Google Scholar] [CrossRef] [PubMed]
- Fernandes, B.S.; Karmakar, C.; Tamouza, R.; Tran, T.; Yearwood, J.; Hamdani, N.; Laouamri, H.; Richard, J.-R.; Yolken, R.; Berk, M. Precision psychiatry with immunological and cognitive biomarkers: A multi-domain prediction for the diagnosis of bipolar disorder or schizophrenia using machine learning. Transl. Psychiatry 2020, 10, 162. [Google Scholar] [CrossRef]
- Karaglani, M.; Agorastos, A.; Panagopoulou, M.; Parlapani, E.; Athanasis, P.; Bitsios, P.; Tzitzikou, K.; Theodosiou, T.; Iliopoulos, I.; Bozikas, V.-P. A novel blood-based epigenetic biosignature in first-episode schizophrenia patients through automated machine learning. Transl. Psychiatry 2024, 14, 257. [Google Scholar] [CrossRef]
- Sánchez-Carro, Y.; de la Torre-Luque, A.; Leal-Leturia, I.; Salvat-Pujol, N.; Massaneda, C.; de Arriba-Arnau, A.; Urretavizcaya, M.; Pérez-Solà, V.; Toll, A.; Martínez-Ruiz, A. Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2023, 121, 110674. [Google Scholar] [CrossRef] [PubMed]
- Wollenhaupt-Aguiar, B.; Librenza-Garcia, D.; Bristot, G.; Przybylski, L.; Stertz, L.; Kubiachi Burque, R.; Ceresér, K.M.; Spanemberg, L.; Caldieraro, M.A.; Frey, B.N. Differential biomarker signatures in unipolar and bipolar depression: A machine learning approach. Aust. N. Zeal. J. Psychiatry 2020, 54, 393–401. [Google Scholar] [CrossRef]
- Mürner-Lavanchy, I.; Koenig, J.; Reichl, C.; Josi, J.; Cavelti, M.; Kaess, M. The quest for a biological phenotype of adolescent non-suicidal self-injury: A machine-learning approach. Transl. Psychiatry 2024, 14, 56. [Google Scholar] [CrossRef]
- Chen, S.; Chen, G.; Li, Y.; Yue, Y.; Zhu, Z.; Li, L.; Jiang, W.; Shen, Z.; Wang, T.; Hou, Z. Predicting the diagnosis of various mental disorders in a mixed cohort using blood-based multi-protein model: A machine learning approach. Eur. Arch. Psychiatry Clin. Neurosci. 2023, 273, 1267–1277. [Google Scholar] [CrossRef]
- Siegel, C.E.; Laska, E.M.; Lin, Z.; Xu, M.; Abu-Amara, D.; Jeffers, M.K.; Qian, M.; Milton, N.; Flory, J.D.; Hammamieh, R. Utilization of machine learning for identifying symptom severity military-related PTSD subtypes and their biological correlates. Transl. Psychiatry 2021, 11, 227. [Google Scholar] [CrossRef]
- Marriott, H.; Kabiljo, R.; Hunt, G.P.; Khleifat, A.A.; Jones, A.; Troakes, C.; Consortium, P.M.A.S.; Consortium, T.S.; Pfaff, A.L.; Quinn, J.P. Unsupervised machine learning identifies distinct ALS molecular subtypes in post-mortem motor cortex and blood expression data. Acta Neuropathol. Commun. 2023, 11, 208. [Google Scholar] [CrossRef]
- Zhu, X.; Wang, C.-l.; Yu, J.-f.; Weng, J.; Han, B.; Liu, Y.; Tang, X.; Pan, B. Identification of immune-related biomarkers in peripheral blood of schizophrenia using bioinformatic methods and machine learning algorithms. Front. Cell. Neurosci. 2023, 17, 1256184. [Google Scholar] [CrossRef] [PubMed]
- Tasci, B.; Tasci, G.; Ayyildiz, H.; Kamath, A.P.; Barua, P.D.; Tuncer, T.; Dogan, S.; Ciaccio, E.J.; Chakraborty, S.; Acharya, U.R. Automated schizophrenia detection model using blood sample scattergram images and local binary pattern. Multimed. Tools Appl. 2024, 83, 42735–42763. [Google Scholar] [CrossRef]
- Cearns, M.; Opel, N.; Clark, S.; Kaehler, C.; Thalamuthu, A.; Heindel, W.; Winter, T.; Teismann, H.; Minnerup, H.; Dannlowski, U. Predicting rehospitalization within 2 years of initial patient admission for a major depressive episode: A multimodal machine learning approach. Transl. Psychiatry 2019, 9, 285. [Google Scholar] [CrossRef] [PubMed]
- Gelir, F.; Akan, T.; Alp, S.; Gecili, E.; Bhuiyan, M.S.; Disbrow, E.A.; Conrad, S.A.; Vanchiere, J.A.; Kevil, C.G.; The Alzheimer’s Disease Neuroimaging Initiative (ADNI) & Mohammad Alfrad Nobel Bhuiyan. Machine Learning Approaches for Predicting Progression to Alzheimer’s Disease in Patients with Mild Cognitive Impairment. J. Med. Biol. Eng. 2024, 1–21. [Google Scholar] [CrossRef]
- Sokolov, A.V.; Schiöth, H.B. Decoding depression: A comprehensive multi-cohort exploration of blood DNA methylation using machine learning and deep learning approaches. Transl. Psychiatry 2024, 14, 287. [Google Scholar] [CrossRef]
- Stamate, D.; Kim, M.; Proitsi, P.; Westwood, S.; Baird, A.; Nevado-Holgado, A.; Hye, A.; Bos, I.; Vos, S.J.; Vandenberghe, R. A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort. Alzheimers Dement. Transl. Res. Clin. Interv. 2019, 5, 933–938. [Google Scholar] [CrossRef]
- Deike, K.; Decker, A.; Scheyhing, P.; Harten, J.; Zimmermann, N.; Paech, D.; Peters, O.; Freiesleben, S.D.; Schneider, L.-S.; Preis, L. Machine Learning–Based Perivascular Space Volumetry in Alzheimer Disease. Investig. Radiol. 2024, 59, 667–676. [Google Scholar] [CrossRef]
- Dogan, M.V.; Beach, S.R.; Simons, R.L.; Lendasse, A.; Penaluna, B.; Philibert, R.A. Blood-based biomarkers for predicting the risk for five-year incident coronary heart disease in the Framingham Heart Study via machine learning. Genes 2018, 9, 641. [Google Scholar] [CrossRef]
- Lu, A.K.-M.; Lin, J.-J.; Tseng, H.-H.; Wang, X.-Y.; Jang, F.-L.; Chen, P.-S.; Huang, C.-C.; Hsieh, S.; Lin, S.-H. DNA methylation signature aberration as potential biomarkers in treatment-resistant schizophrenia: Constructing a methylation risk score using a machine learning method. J. Psychiatr. Res. 2023, 157, 57–65. [Google Scholar] [CrossRef]
- Chekroud, A.M.; Bondar, J.; Delgadillo, J.; Doherty, G.; Wasil, A.; Fokkema, M.; Cohen, Z.; Belgrave, D.; DeRubeis, R.; Iniesta, R. The promise of machine learning in predicting treatment outcomes in psychiatry. World Psychiatry 2021, 20, 154–170. [Google Scholar] [CrossRef]
- Le Glaz, A.; Haralambous, Y.; Kim-Dufor, D.-H.; Lenca, P.; Billot, R.; Ryan, T.C.; Marsh, J.; Devylder, J.; Walter, M.; Berrouiguet, S. Machine learning and natural language processing in mental health: Systematic review. J. Med. Internet Res. 2021, 23, e15708. [Google Scholar] [CrossRef] [PubMed]
- Alvarez-Mon, M.A.; Donat-Vargas, C.; Santoma-Vilaclara, J.; Anta, L.d.; Goena, J.; Sanchez-Bayona, R.; Mora, F.; Ortega, M.A.; Lahera, G.; Rodriguez-Jimenez, R. Assessment of antipsychotic medications on social media: Machine learning study. Front. Psychiatry 2021, 12, 737684. [Google Scholar] [CrossRef] [PubMed]
- Lin, S.-Y.; Cheng, X.; Zhang, J.; Yannam, J.S.; Barnes, A.J.; Koch, J.R.; Hayes, R.; Gimm, G.; Zhao, X.; Purohit, H. Social media data mining of antitobacco campaign messages: Machine learning analysis of facebook posts. J. Med. Internet Res. 2023, 25, e42863. [Google Scholar] [CrossRef]
- Kim, D.; Quan, L.; Seo, M.; Kim, K.; Kim, J.W.; Zhu, Y. Interpretable machine learning-based approaches for understanding suicide risk and protective factors among South Korean females using survey and social media data. Suicide Life-Threat. Behav. 2023, 53, 484–498. [Google Scholar] [CrossRef] [PubMed]
- Bernert, R.A.; Hilberg, A.M.; Melia, R.; Kim, J.P.; Shah, N.H.; Abnousi, F. Artificial intelligence and suicide prevention: A systematic review of machine learning investigations. Int. J. Environ. Res. Public Health 2020, 17, 5929. [Google Scholar] [CrossRef]
- Kaminsky, Z.; McQuaid, R.J.; Hellemans, K.G.; Patterson, Z.R.; Saad, M.; Gabrys, R.L.; Kendzerska, T.; Abizaid, A.; Robillard, R. Machine Learning–Based Suicide Risk Prediction Model for Suicidal Trajectory on Social Media Following Suicidal Mentions: Independent Algorithm Validation. J. Med. Internet Res. 2024, 26, e49927. [Google Scholar] [CrossRef]
- Roy, A.; Nikolitch, K.; McGinn, R.; Jinah, S.; Klement, W.; Kaminsky, Z.A. A machine learning approach predicts future risk to suicidal ideation from social media data. NPJ Digit. Med. 2020, 3, 1–12. [Google Scholar] [CrossRef]
- de Anta, L.; Alvarez-Mon, M.Á.; Pereira-Sanchez, V.; Donat-Vargas, C.C.; Lara-Abelenda, F.J.; Arrieta, M.; Montero-Torres, M.; García-Montero, C.; Fraile-Martínez, Ó.; Mora, F. Assessment of beliefs and attitudes towards benzodiazepines using machine learning based on social media posts: An observational study. BMC Psychiatry 2024, 24, 659. [Google Scholar] [CrossRef]
- Erturk, S.; Hudson, G.; Jansli, S.M.; Morris, D.; Odoi, C.M.; Wilson, E.; Clayton-Turner, A.; Bray, V.; Yourston, G.; Cornwall, A. Codeveloping and Evaluating a Campaign to Reduce Dementia Misconceptions on Twitter: Machine Learning Study. JMIR Infodemiology 2022, 2, e36871. [Google Scholar] [CrossRef]
- Ryu, J.; Sükei, E.; Norbury, A.; Liu, S.H.; Campaña-Montes, J.J.; Baca-Garcia, E.; Artés, A.; Perez-Rodriguez, M.M. Shift in social media app usage during COVID-19 lockdown and clinical anxiety symptoms: Machine learning–based ecological momentary assessment study. JMIR Ment. Health 2021, 8, e30833. [Google Scholar] [CrossRef]
- Lim, S.R.; Ng, Q.X.; Xin, X.; Lim, Y.L.; Boon, E.S.K.; Liew, T.M. Public discourse surrounding suicide during the COVID-19 pandemic: An unsupervised machine learning analysis of Twitter posts over a one-year period. Int. J. Environ. Res. Public Health 2022, 19, 13834. [Google Scholar] [CrossRef] [PubMed]
- Joyce, D.W.; Kormilitzin, A.; Hamer-Hunt, J.; McKee, K.R.; Tomasev, N. Defining acceptable data collection and reuse standards for queer artificial intelligence research in mental health: Protocol for the online PARQAIR-MH Delphi study. BMJ Open 2024, 14, e079105. [Google Scholar] [CrossRef] [PubMed]
- Lee, E.E.; Torous, J.; De Choudhury, M.; Depp, C.A.; Graham, S.A.; Kim, H.-C.; Paulus, M.P.; Krystal, J.H.; Jeste, D.V. Artificial intelligence for mental health care: Clinical applications, barriers, facilitators, and artificial wisdom. Biol. Psychiatry: Cogn. Neurosci. Neuroimaging 2021, 6, 856–864. [Google Scholar] [CrossRef] [PubMed]
- Kelly, D.; Coppersmith, G.; Dickerson, J.; Espy-Wilson, C.; Michel, H.; Resnik, P. Computationally Scalable and Clinically Sound: Laying the Groundwork to Use Machine Learning Techniques for Social Media and Language Data in Predicting Psychiatric Symptoms. Biol. Psychiatry 2022, 91, S50. [Google Scholar] [CrossRef]
- Graham, S.; Depp, C.; Lee, E.E.; Nebeker, C.; Tu, X.; Kim, H.-C.; Jeste, D.V. Artificial intelligence for mental health and mental illnesses: An overview. Curr. Psychiatry Rep. 2019, 21, 1–18. [Google Scholar] [CrossRef]
- Gargari, O.K.; Fatehi, F.; Mohammadi, I.; Firouzabadi, S.R.; Shafiee, A.; Habibi, G. Diagnostic accuracy of large language models in psychiatry. Asian J. Psychiatry 2024, 100, 104168. [Google Scholar] [CrossRef]
- Turner, R.J.; Coenen, F.; Roelofs, F.; Hagoort, K.; Härmä, A.; Grünwald, P.D.; Velders, F.P.; Scheepers, F.E. Information extraction from free text for aiding transdiagnostic psychiatry: Constructing NLP pipelines tailored to clinicians’ needs. BMC Psychiatry 2022, 22, 407. [Google Scholar] [CrossRef]
- Botelle, R.; Bhavsar, V.; Kadra-Scalzo, G.; Mascio, A.; Williams, M.V.; Roberts, A.; Velupillai, S.; Stewart, R. Can natural language processing models extract and classify instances of interpersonal violence in mental healthcare electronic records: An applied evaluative study. BMJ Open 2022, 12, e052911. [Google Scholar] [CrossRef]
- Levis, M.; Levy, J.; Dufort, V.; Gobbel, G.T.; Watts, B.V.; Shiner, B. Leveraging unstructured electronic medical record notes to derive population-specific suicide risk models. Psychiatry Res. 2022, 315, 114703. [Google Scholar] [CrossRef]
- Levis, M.; Levy, J.; Dent, K.R.; Dufort, V.; Gobbel, G.T.; Watts, B.V.; Shiner, B. Leveraging natural language processing to improve electronic health record suicide risk prediction for Veterans Health Administration users. J. Clin. Psychiatry 2023, 84, 47557. [Google Scholar] [CrossRef]
- Tsui, F.R.; Shi, L.; Ruiz, V.; Ryan, N.D.; Biernesser, C.; Iyengar, S.; Walsh, C.G.; Brent, D.A. Natural language processing and machine learning of electronic health records for prediction of first-time suicide attempts. JAMIA Open 2021, 4, ooab011. [Google Scholar] [CrossRef] [PubMed]
- Çabuk, T.; Sevim, N.; Mutlu, E.; Yağcıoğlu, A.E.A.; Koç, A.; Toulopoulou, T. Natural language processing for defining linguistic features in schizophrenia: A sample from Turkish speakers. Schizophr. Res. 2024, 266, 183–189. [Google Scholar] [CrossRef] [PubMed]
- Arslan, B.; Kizilay, E.; Verim, B.; Demirlek, C.; Dokuyan, Y.; Turan, Y.E.; Kucukakdag, A.; Demir, M.; Cesim, E.; Bora, E. Automated linguistic analysis in speech samples of Turkish-speaking patients with schizophrenia-spectrum disorders. Schizophr. Res. 2024, 267, 65–71. [Google Scholar] [CrossRef] [PubMed]
- Zaher, F.; Diallo, M.; Achim, A.M.; Joober, R.; Roy, M.-A.; Demers, M.-F.; Subramanian, P.; Lavigne, K.M.; Lepage, M.; Gonzalez, D. Speech markers to predict and prevent recurrent episodes of psychosis: A narrative overview and emerging opportunities. Schizophr. Res. 2024, 266, 205–215. [Google Scholar] [CrossRef]
- Benger, M.; Wood, D.A.; Kafiabadi, S.; Al Busaidi, A.; Guilhem, E.; Lynch, J.; Townend, M.; Montvila, A.; Siddiqui, J.; Gadapa, N. Factors affecting the labelling accuracy of brain MRI studies relevant for deep learning abnormality detection. Front. Radiol. 2023, 3, 1251825. [Google Scholar] [CrossRef]
- Wang, L.; Zhang, Y.; Chignell, M.; Shan, B.; Sheehan, K.A.; Razak, F.; Verma, A. Boosting delirium identification accuracy with sentiment-based natural language processing: Mixed methods study. JMIR Med. Inform. 2022, 10, e38161. [Google Scholar] [CrossRef]
- Ciampelli, S.; Voppel, A.; De Boer, J.; Koops, S.; Sommer, I. Combining automatic speech recognition with semantic natural language processing in schizophrenia. Psychiatry Res. 2023, 325, 115252. [Google Scholar] [CrossRef]
- Vaci, N.; Liu, Q.; Kormilitzin, A.; De Crescenzo, F.; Kurtulmus, A.; Harvey, J.; O’Dell, B.; Innocent, S.; Tomlinson, A.; Cipriani, A. Natural language processing for structuring clinical text data on depression using UK-CRIS. BMJ Ment. Health 2020, 23, 21–26. [Google Scholar] [CrossRef]
- Kerz, E.; Zanwar, S.; Qiao, Y.; Wiechmann, D. Toward explainable AI (XAI) for mental health detection based on language behavior. Front. Psychiatry 2023, 14, 1219479. [Google Scholar] [CrossRef]
- Sawalha, J.; Yousefnezhad, M.; Shah, Z.; Brown, M.R.; Greenshaw, A.J.; Greiner, R. Detecting presence of PTSD using sentiment analysis from text data. Front. Psychiatry 2022, 12, 811392. [Google Scholar] [CrossRef]
- Acosta, M.J.; Castillo-Sánchez, G.; Garcia-Zapirain, B.; De la Torre Diez, I.; Franco-Martín, M. Sentiment analysis techniques applied to raw-text data from a csq-8 questionnaire about mindfulness in times of covid-19 to improve strategy generation. Int. J. Environ. Res. Public Health 2021, 18, 6408. [Google Scholar] [CrossRef]
- Kizilay, E.; Arslan, B.; Verim, B.; Demirlek, C.; Demir, M.; Cesim, E.; Eyuboglu, M.S.; Ozbek, S.U.; Sut, E.; Yalincetin, B. Automated linguistic analysis in youth at clinical high risk for psychosis. Schizophr. Res. 2024, 274, 121–128. [Google Scholar] [CrossRef] [PubMed]
- Cox, D.J.; Garcia-Romeu, A.; Johnson, M.W. Predicting changes in substance use following psychedelic experiences: Natural language processing of psychedelic session narratives. Am. J. Drug Alcohol Abus. 2021, 47, 444–454. [Google Scholar] [CrossRef] [PubMed]
- Irving, J.; Patel, R.; Oliver, D.; Colling, C.; Pritchard, M.; Broadbent, M.; Baldwin, H.; Stahl, D.; Stewart, R.; Fusar-Poli, P. Using natural language processing on electronic health records to enhance detection and prediction of psychosis risk. Schizophr. Bull. 2021, 47, 405–414. [Google Scholar] [CrossRef]
- Wu, H.; Hodgson, K.; Dyson, S.; Morley, K.I.; Ibrahim, Z.M.; Iqbal, E.; Stewart, R.; Dobson, R.J.; Sudlow, C. Efficient reuse of natural language processing models for phenotype-mention identification in free-text electronic medical records: A phenotype embedding approach. JMIR Med. Inform. 2019, 7, e14782. [Google Scholar] [CrossRef] [PubMed]
- Horigome, T.; Hino, K.; Toyoshiba, H.; Shindo, N.; Funaki, K.; Eguchi, Y.; Kitazawa, M.; Fujita, T.; Mimura, M.; Kishimoto, T. Identifying neurocognitive disorder using vector representation of free conversation. Sci. Rep. 2022, 12, 12461. [Google Scholar] [CrossRef] [PubMed]
- Viani, N.; Kam, J.; Yin, L.; Bittar, A.; Dutta, R.; Patel, R.; Stewart, R.; Velupillai, S. Temporal information extraction from mental health records to identify duration of untreated psychosis. J. Biomed. Semant. 2020, 11, 1–11. [Google Scholar] [CrossRef]
- Oh, I.Y.; Schindler, S.E.; Ghoshal, N.; Lai, A.M.; Payne, P.R.; Gupta, A. Extraction of clinical phenotypes for Alzheimer’s disease dementia from clinical notes using natural language processing. JAMIA Open 2023, 6, ooad014. [Google Scholar] [CrossRef]
- Arslan, B.; Kizilay, E.; Verim, B.; Demirlek, C.; Demir, M.; Cesim, E.; Eyuboglu, M.S.; Ozbek, S.U.; Sut, E.; Yalincetin, B. Computational analysis of linguistic features in speech samples of first-episode bipolar disorder and psychosis. J. Affect. Disord. 2024, 363, 340–347. [Google Scholar] [CrossRef]
- Msosa, Y.J.; Grauslys, A.; Zhou, Y.; Wang, T.; Buchan, I.; Langan, P.; Foster, S.; Walker, M.; Pearson, M.; Folarin, A. Trustworthy Data and AI Environments for Clinical Prediction: Application to Crisis-Risk in People With Depression. IEEE J. Biomed. Health Inform. 2023, 27, 5588–5598. [Google Scholar] [CrossRef]
- Furukawa, T.A.; Iwata, S.; Horikoshi, M.; Sakata, M.; Toyomoto, R.; Luo, Y.; Tajika, A.; Kudo, N.; Aramaki, E. Harnessing AI to Optimize Thought Records and Facilitate Cognitive Restructuring in Smartphone CBT: An Exploratory Study. Cogn. Ther. Res. 2023, 47, 887–893. [Google Scholar] [CrossRef]
- Kosowan, L.; Singer, A.; Zulkernine, F.; Zafari, H.; Nesca, M.; Muthumuni, D. Pan-Canadian Electronic Medical Record Diagnostic and Unstructured Text Data for Capturing PTSD: Retrospective Observational Study. JMIR Med. Inform. 2022, 10, e41312. [Google Scholar] [CrossRef] [PubMed]
- Meerwijk, E.L.; Tamang, S.R.; Finlay, A.K.; Ilgen, M.A.; Reeves, R.M.; Harris, A.H. Suicide theory-guided natural language processing of clinical progress notes to improve prediction of veteran suicide risk: Protocol for a mixed-method study. BMJ Open 2022, 12, e065088. [Google Scholar] [CrossRef] [PubMed]
- Cusick, M.; Adekkanattu, P.; Campion, T.R., Jr.; Sholle, E.T.; Myers, A.; Banerjee, S.; Alexopoulos, G.; Wang, Y.; Pathak, J. Using weak supervision and deep learning to classify clinical notes for identification of current suicidal ideation. J. Psychiatr. Res. 2021, 136, 95–102. [Google Scholar] [CrossRef]
- Iqbal, E.; Mallah, R.; Rhodes, D.; Wu, H.; Romero, A.; Chang, N.; Dzahini, O.; Pandey, C.; Broadbent, M.; Stewart, R. ADEPt, a semantically-enriched pipeline for extracting adverse drug events from free-text electronic health records. PLoS ONE 2017, 12, e0187121. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).